For most of the post-2010 era, global equity indices were highly correlated. When the S&P 500 had a bad day, the DAX, FTSE, Nikkei, and Hang Seng usually had bad days too. The correlations reflected the dominance of the US-tech-and-Fed-policy macro narrative — every index was effectively a beta-adjusted bet on the same underlying global liquidity and growth conditions.
That regime has weakened materially in 2025 and 2026. Rolling 60-day correlations between the major regional indices have dropped to multi-year lows. The same Fed-decision week can produce very different reactions across regions. The driver is index composition: each major index is now dominated by a specific sector exposure that is responding to its own narrative. Trading them as interchangeable beta vehicles will keep producing surprising results.
This article walks through what each major index is actually exposed to in 2026, why they have decoupled, and what each is currently telling you about its underlying economy and sector cohort.
S&P 500: tech-concentrated, breadth-weak
The S&P 500's top 10 names (the magnificent-seven tech stocks plus Berkshire, JPMorgan, and one rotating addition) account for over 35% of the index by market cap. That is the highest concentration since the late 1990s tech bubble. The other 490 stocks contribute proportionally less to index movement than they did at any point in the last 20 years.
The implication: the S&P 500 is now functionally a leveraged bet on US mega-cap tech. When you 'buy the S&P', you are buying 35-40% AI/tech megacap, 15-20% financials, 10-12% healthcare, and a long tail of everything else. The historical analytical framework of treating S&P as a diversified equity exposure has become misleading.
What S&P is telling you in 2026: it is telling you what the mega-cap tech earnings story is doing. The breadth (advance-decline line, equal-weight S&P) has lagged the headline for most of the year. A market-cap-weighted index at all-time highs while the equal-weight index struggles is one of the clearer divergences in the data.
NASDAQ-100: more concentrated, more cyclical to one variable
The NASDAQ-100 is the more extreme version of the S&P concentration story. The top 7 names approach 50% of the index. The single largest variable driving the index has been AI-infrastructure capex (chips, hyperscalers, data centres). When that capex narrative is intact, NDX outperforms. When it questions itself (a hyperscaler guidance miss, a Nvidia inventory comment), the index drops faster than diversified equity benchmarks.
What NASDAQ is telling you: the state of the AI-infrastructure investment cycle. The cycle is not over but is unmistakably more questioned in 2026 than it was in 2024. Hyperscaler capex growth has decelerated from triple-digit-percent year-over-year to high-double-digit. The question of when (not if) capex growth normalises to a sustainable run rate is the question driving daily NDX direction.
DAX 40: industrial-cyclical, with a European-specific twist
The DAX is the cleanest single index of European industrial exposure. Cars (BMW, Mercedes, VW, Porsche), chemicals (BASF, Bayer), engineering (Siemens, ABB), and defence (Rheinmetall) collectively dominate. The constituents earn a significant share of revenue in USD, which makes the index sensitive to EUR/USD direction in both directions — strong USD lifts translated earnings, weak USD compresses them.
What DAX is telling you in 2026: European industrials are doing better than the macro narrative suggested. The 2024 narrative was that European industry was structurally damaged by energy costs, China demand weakness, and Chinese EV competition. The 2025-2026 data is more nuanced — German chemicals stabilised, industrials reported beats on lower expectations, defence cyclical continued strong on sustained government commitments. The DAX outperformed the S&P year-to-date in EUR terms despite all the catastrophist framing.
The vulnerability: DAX is exposed to a hypothetical US-tariff escalation aimed specifically at European autos or steel. The Trump administration's commercial-policy posture is the single largest swing variable in the DAX's 2026 outcome.
FTSE 100: energy, defence, banking, with a sterling kicker
The FTSE 100 is dominated by the energy majors (Shell, BP), pharma (AstraZeneca, GSK), miners (Rio Tinto, Glencore), banks (HSBC, Lloyds), and consumer staples (Unilever, Diageo). It has almost no exposure to the AI mega-cap tech cohort that drives the S&P.
What FTSE is telling you: commodity prices, dollar strength (most constituents earn in USD or USD-linked currencies), and global financial conditions. A high oil price is good for FTSE; a weak dollar is mostly bad. The index has been a quiet outperformer over the last 12 months and a textbook example of why regional dispersion is back.
Nikkei 225: corporate-governance reform vs JPY direction
The Nikkei 225 was rangebound for two decades and then made new all-time highs in 2024, breaking out of a 35-year base. The proximate driver was the multi-year corporate-governance reform that pressured Japanese corporates to improve capital allocation, return cash to shareholders, and disclose more on a market-comparable basis.
What Nikkei is telling you in 2026: the corporate-governance reform story is intact, but JPY direction is now the dominant short-term variable. A weak JPY supports Nikkei (USD-earner constituents benefit, foreign capital inflows continue). A strong JPY (typically driven by BoJ rate normalisation or US growth softening) compresses Nikkei. The cleanest cross-check on Nikkei direction is USD/JPY.
Why the decoupling matters for traders
If you take a position based on a single macro thesis (e.g., 'Fed will cut and risk assets will rally'), but you implement that position via, say, DAX rather than S&P, you may be right on the macro and wrong on the index because the DAX-specific story diverges from the S&P story. The same Fed-cut surprise could lift the S&P (lower rates good for tech multiples), be neutral for DAX (lower USD compresses translated earnings, offsetting), and lift FTSE (lower USD bad for USD-earners, but the broader risk-on supports commodities). Generic 'long equities' has become a less coherent trade than it was even three years ago.
The practical implication: indices need to be selected for the specific exposure you want, not as interchangeable global equity beta. If you want AI capex exposure, NDX. If you want European industrial recovery exposure, DAX. If you want commodity-and-defence exposure, FTSE. Trading 'the market' is no longer a coherent thesis.
Cross-index spread trades have re-emerged
The divergence has opened up cross-index relative-value trades that didn't exist when correlations were tight. Long DAX / short S&P based on European industrial outperformance has worked in EUR terms year-to-date. Long Nikkei / short S&P based on Japanese corporate governance has produced steady alpha through 2025-2026. Long FTSE / short NDX in periods of dollar weakness and energy strength has been profitable in specific windows.
These trades carry currency risk that often dominates the equity-vs-equity P/L. Hedging the FX leg or explicitly accepting that exposure is the first decision; the spread call is the second. Doing it the other way around is one of the cleaner ways to get the macro right and the P&L wrong.
What to watch into year-end
- Hyperscaler capex guidance: directly drives NDX, indirectly drives S&P via concentration.
- China industrial activity prints: drives DAX via German export exposure, drives FTSE via mining constituents.
- EU-US trade-policy headlines: directly drives DAX via auto/steel exposure.
- BoJ rate path: drives Nikkei via JPY direction.
- Oil prices: drives FTSE via energy majors, indirectly drives Nikkei via importer-economy exposure.